Activity of anti-epidermal growth factor receptor monoclonal antibody C225 against glioblastoma multiforme. (Q55473253)

12 July 2018

title

Activity of anti-epidermal growth factor receptor monoclonal antibody C225 against glioblastoma multiforme. (English)

1 reference

12 July 2018

1 reference

1 reference

1 reference

Daniel J Hicklin

1 reference

12 July 2018

author name string

Jorge L Eller

series ordinal

1 reference

12 July 2018

Sharon L Longo

series ordinal

1 reference

12 July 2018

Gregory W Canute

series ordinal

1 reference

12 July 2018

language of work or name

English

0 references

publication date

1 October 2002

1 reference

12 July 2018

published in

Neurosurgery

1 reference

12 July 2018

volume

1 reference

12 July 2018

issue

1 reference

12 July 2018

page(s)

1005-13; discussion 1013-4

1 reference

12 July 2018

Receptor blockade with monoclonal antibodies as anti-cancer therapy

cites work

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Patient age, histologic features, and length of survival in patients with glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

The hydroxyurea-induced loss of double-minute chromosomes containing amplified epidermal growth factor receptor genes reduces the tumorigenicity and growth of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Effects of EGF, bFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain-tumour biopsies in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Targeted toxin therapy for malignant astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Specific targeting of a mutant, activated egf receptor found in glioblastoma using a monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Dose escalation with repeated intrathecal injections of 131I-labelled MAbs for the treatment of central nervous system malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Allele loss on chromosomes 10 and 17p and epidermal growth factor receptor gene amplification in human malignant astrocytoma related to prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Anti-EGFR monoclonal antibodies which act as EGF, TGFα, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Human glioma immunobiology in vitro: implications for immunogene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Response of malignant glioma cell lines to epidermal growth factor and platelet-derived growth factor in a serum-free medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

131I radioconjugated antibodies for the locoregional radioimmunotherapy of high-grade malignant glioma--phase I and II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Chemotherapy and immunotherapy of malignant glioma: molecular mechanisms and clinical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Long-term survival in patients with malignant astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Epidermal growth factor-related peptides and their receptors in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Apoptosis and cell proliferation in human neuroepithelial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Variable Efficiency of the Thymidine Kinase/Ganciclovir System in Human Glioblastoma Cell Lines: Implications for Gene Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Monoclonal antibody against epidermal growth factor receptor is internalized without stimulating receptor phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

The autocrine loop of TGF-alpha/EGFR and brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Signal transduction by receptors with tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Receptor protein-tyrosine kinases and their signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Molecular pathways in the formation of gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Monoclonal antibody therapy of human gliomas: current status and future approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

The epidermal growth factor receptor and its inhibition in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Cellular and molecular neurosurgery: pathways from concept to reality--part I: target disorders and concept approaches to gene therapy of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

Cellular and molecular neurosurgery: pathways from concept to reality--part II: vector systems and delivery methodologies for gene therapy of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00006123-200210000-00028

10.1097/00006123-200210000-00028

21 January 2018

Identifiers

DOI

1 reference

12 July 2018

1 reference

12 July 2018